Coya Therapeutics (COYA) Cash & Equivalents (2021 - 2026)
Coya Therapeutics (COYA) recorded Cash & Equivalents of $43.2 million in Q2 2026, up 45.0% from $29.8 million a year earlier but down 14.8% from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Coya Therapeutics reported Cash & Equivalents of $46.82 million, up 22.1% from FY2024.
- Annual Cash & Equivalents has increased for four straight years, with a four-year compound annual growth rate of 81.2% (FY2021 to FY2025).
- Across earlier years, Cash & Equivalents came in at $38.34 million in FY2024 (+17.5%), $32.63 million in FY2023 (+449.9%), $5.93 million in FY2022 (+36.7%) and $4.34 million in FY2021.
- Quarterly Cash & Equivalents has ranged from $4.34 million in Q4 2021 to $50.72 million in Q1 2026 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 35.5% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 449.9% in Q4 2023, against a decline of 18.6% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $50.72 million (Q1 2026), $46.82 million (Q4 2025) and $28.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Coya Therapeutics | 92.42 Mn | -76.45 Mn | - | 43.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.20 Mn |
| Mar 31, 2026 | 50.72 Mn |
| Dec 31, 2025 | 46.82 Mn |
| Sep 30, 2025 | 28.13 Mn |
| Jun 30, 2025 | 29.80 Mn |
| Mar 31, 2025 | 35.53 Mn |
| Dec 31, 2024 | 38.34 Mn |
| Sep 30, 2024 | 31.10 Mn |
| Jun 30, 2024 | 36.60 Mn |
| Mar 31, 2024 | 36.00 Mn |
| Dec 31, 2023 | 32.63 Mn |
| Sep 30, 2023 | 10.89 Mn |
| Jun 30, 2023 | 13.10 Mn |
| Mar 31, 2023 | 16.32 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Dec 31, 2021 | 4.34 Mn |
API Access
Coya Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();